| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 48.28× | 48.28× | 47.13× | 33.08× | 25.62× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.30× | 0.31× | 0.34× | 0.40× | 0.46× | ||
| 0.23× | 0.23× | 0.25× | 0.28× | 0.31× | ||
| −0.10× | −0.10× | 0.09× | 0.39× | 0.59× | ||
| −0.24× | −0.24× | 0.16× | 0.54× | 0.92× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 25.62 | 33.08 | 47.13 | 48.28 | 48.28 | |
| Working Capital Turnover | 0.46 | 0.40 | 0.34 | 0.31 | 0.30 | |
| Asset Turnover | 0.31 | 0.28 | 0.25 | 0.23 | 0.23 | |
| Cash Conversion (CFO/Net Income) | 0.59 | 0.39 | 0.09 | -0.10 | -0.10 | |
| CFO/EBITDA | 0.92 | 0.54 | 0.16 | -0.24 | -0.24 |